Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Prospective Evaluation of Optical Coherence Tomography Usage in the Screening of Eye Diseases
Authors not listed
Oregon Health and Science University · 2012
Abstract
The primary goal of the trial is to show that optical coherence tomography (OCT) technology can be used to effectively screen for diseases of the eye including glaucoma, macular diseases and keratoconus. Glaucoma is a disease that causes permanent vision loss and is usually accompanied by increased eye pressure. Macular diseases affect sharp, central vision. Keratoconus is a disease that affects the cornea (clear surface covering the colored part of the eye).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Anonymous. (2012). Prospective Evaluation of Optical Coherence Tomography Usage in the Screening of Eye Diseases. <em>Oregon Health and Science University</em>. https://clinicaltrials.gov/study/NCT01510392
Vancouver
Anonymous. Prospective Evaluation of Optical Coherence Tomography Usage in the Screening of Eye Diseases. Oregon Health and Science University. 2012.
BibTeX
@misc{anon2012Prospe,
title = {Prospective Evaluation of Optical Coherence Tomography Usage in the Screening of Eye Diseases},
author = {Anonymous},
journal = {Oregon Health and Science University},
year = {2012},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Survey of Ophthalmology 2012
Citation only
Evaluation of Age-related Macular Degeneration With Optical Coherence Tomography
Progress in Retinal and Eye Research 2018
Open access · CC-BY
Stemming retinal regeneration with pluripotent stem cells
University of California, San Francisco 2019
Open access · US-GOV
Village-Integrated Eye Worker Trial II (VIEW II):A Cluster-randomized Trial of the Effectiveness of Community-based Ocular Disease Screening
Retinow Health Technologies and R&D Industry Joint Stock Company 2023
Open access · US-GOV
Analysis of Diabetic Retinopathy, Glaucoma and Macular Degeneration Diagnosis Via Digital Fundus Images With Artificial Intelligence
Hematology 2009
Open access · OA
Telomeres and marrow failure
Ageing Research Reviews 2024
Open access · CC-BY